CATALOGO DEI PRODOTTI DELLA RICERCA

ZANOTTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.893
EU - Europa 2.717
AS - Asia 1.373
SA - Sud America 24
OC - Oceania 11
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.881
GB - Regno Unito 1.039
CN - Cina 955
SE - Svezia 334
SG - Singapore 313
IT - Italia 235
FR - Francia 210
IE - Irlanda 200
RU - Federazione Russa 193
DE - Germania 174
FI - Finlandia 165
UA - Ucraina 45
NL - Olanda 36
BE - Belgio 33
TR - Turchia 23
JP - Giappone 19
VN - Vietnam 15
BR - Brasile 10
KR - Corea 10
AU - Australia 9
CA - Canada 9
AT - Austria 8
ES - Italia 8
IN - India 6
IR - Iran 6
CH - Svizzera 5
PE - Perù 5
CL - Cile 4
GR - Grecia 4
ID - Indonesia 4
LT - Lituania 4
RO - Romania 4
AR - Argentina 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MX - Messico 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TH - Thailandia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
KH - Cambogia 1
MN - Mongolia 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TG - Togo 1
TM - Turkmenistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 7.030
Salva come PNG Salva come JPEG
Città #
Southend 928
Chandler 511
Jacksonville 320
Woodbridge 304
Ann Arbor 293
Singapore 278
Beijing 237
Dublin 198
Ashburn 170
Houston 155
Wilmington 106
New York 93
Jinan 88
Lawrence 80
Princeton 80
Nanjing 65
Shenyang 55
Verona 49
Helsinki 48
Hebei 39
Bologna 36
Tianjin 36
Brussels 33
Ningbo 33
Taizhou 29
Zhengzhou 29
Haikou 28
Hangzhou 28
Changsha 27
Boardman 25
Groningen 21
Nanchang 21
Sindelfingen 21
Guangzhou 20
Milan 19
Jiaxing 17
Norwalk 17
Taiyuan 16
Tokyo 16
Chicago 15
Dearborn 15
Redwood City 15
Seattle 15
Falls Church 13
Lancaster 12
Los Angeles 12
Manchester 12
Dong Ket 11
Fuzhou 10
Lanzhou 10
Santa Clara 10
Seoul 9
Düsseldorf 8
Fairfield 8
Redmond 8
São Paulo 8
Vienna 8
Washington 8
Rome 7
Ardabil 6
Dallas 6
Denver 6
Moscow 6
Riva 6
Amsterdam 5
Clearwater 5
Kent 5
Lima 5
San Mateo 5
Tappahannock 5
Athens 4
Jakarta 4
Monmouth Junction 4
Munich 4
Nürnberg 4
Qingdao 4
Stockholm 4
Toronto 4
Atlanta 3
Augusta 3
Cambridge 3
Catania 3
Detroit 3
Genoa 3
Grafing 3
Hefei 3
Irving 3
Isola della Scala 3
Leawood 3
London 3
Mateur 3
Melbourne 3
Newark 3
Nuremberg 3
Philadelphia 3
Recanati 3
Riga 3
San Diego 3
Santiago Metropolitan 3
Shanghai 3
Totale 4.941
Salva come PNG Salva come JPEG
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 225
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 145
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 144
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 140
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 140
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 139
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 137
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 133
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 129
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 122
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 121
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 120
BCR-signaling profiles associated with prognosis and progression in B-CLL 118
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 114
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 112
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 109
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 109
BCR-signaling profiles associated with prognosis and progression in B-CLL 109
Underdiagnosed systemic mastocytosis: The role of flow cytometry 108
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 107
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 106
Osteopetrosi 104
Prevalence of osteoporosis in patients affected by mastocytosis 102
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 101
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 101
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 100
Bone involvement and osteoporosis in mastocytosis. 96
The high oxygen affinity haemoglobin Nantes: a family case description 96
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 95
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 95
Bone involvement in patient with clonal mast cell disorders 95
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 95
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 94
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 93
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 92
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 92
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 91
Effects of denosumab on peripheral lymphocyte subpopulations 91
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 88
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 87
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 87
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 86
Vaccination Management In Children and Adults With Mastocytosis 86
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 84
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 84
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 83
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 81
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 81
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 80
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 80
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 80
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 79
Single Cell Network Profiling (SCNP) assay reveals B Cell Receptor Signaling heterogeneity in the Context of ZAP-70 Expression in patients with Chronic Lymphocytic Leukemia (CLL) 78
Bone Disease in Mastocytosis 77
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 76
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 75
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 73
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 65
Mastocytosis and insect venom allergy 64
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 63
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 62
Mastocytosis and allergic diseases 61
Mast Cell Disorders In Drug Hypersensitivity 61
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 59
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 59
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 59
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 59
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 57
Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. 56
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 54
Systemic Mastocytosis 53
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 51
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 48
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 48
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 47
null 44
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 43
Hymenoptera Allergy and Mast Cell Activation Syndromes 40
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study 33
Letter to the Editor: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis 26
Night shift work and lymphoma: results from an Italian multicentre case-control study 26
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 12
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 9
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 3
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 2
Totale 7.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.235
article - articoli 16.045
book - libri 0
conference - conferenze 7.190
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020515 0 0 0 0 0 95 95 52 45 81 63 84
2020/2021794 84 164 37 79 78 79 14 30 26 10 156 37
2021/2022744 55 237 8 91 42 19 21 42 35 22 39 133
2022/20231.442 92 170 114 292 92 362 30 76 163 10 26 15
2023/2024773 57 66 47 69 88 132 37 71 5 39 123 39
2024/2025730 85 126 98 300 80 41 0 0 0 0 0 0
Totale 7.129